Regulating Metal–Support Interaction via WO 3 Crystal Phase Engineering for Enhanced Acidic Water Oxidation
Angewandte Chemie International Edition · 02.11.2026 · 65 (45)
DOI: 10.1002/anie.7046071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 22.09.2026. Verfasst von Chaolong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Center for Sustainable Energy Science and Engineering (IRC4SE2), National Key Laboratory of Special Rare Metal Materials, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Henan Province's Central Plains Talent Program (Cultivation Series)-Young Top Talents of Central Plains, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Metal–support interaction (MSI) is pivotal in tuning the intrinsic activity and structural stability of heterogeneous catalysts, yet precise control of MSI strength remains a major challenge. Herein, we demonstrate crystal‐phase engineering of WO 3 supports—monoclinic (M‐WO 3 ), orthorhombic (O‐WO 3 ), and tetragonal (T‐WO 3 )—to modulate MSI in Ir single‐atom catalysts. The three WO 3 crystals exhibit distinct distortion degrees (M‐WO 3 > O‐WO 3 > T‐WO 3 ), where stronger distortion enhances Ir activity but compromises stability. Notably, O‐WO 3 achieves an optimal modulation balance: the moderate W─O bond strength and distortion induce the strongest MSI, elevating the Ir oxidation state to +5.74, shortening the Ir─O bond, and reinforcing Ir─O covalency. Such favorable electronic and structural modulation substantially promotes intrinsic oxygen evolution reaction (OER) activity. The O─WO 3 ─Ir catalyst exhibits a low overpotential of 219 mV at 10 mA cm −2 and demonstrates outstanding acidic OER stability, with a cumulative operation time over 1000 h under sequential testing at different current densities. The optimized MSI promotes high‐valence Ir formation, accelerates *OO intermediate generation, and suppresses Ir dissolution, thereby addressing sluggish kinetics and unstable active sites. This work provides new insights into regulating MSI strength via crystal‐phase engineering to advance durable and efficient acidic OER catalysts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Research Center for Sustainable Energy Science and Engineering (IRC4SE2), National Key Laboratory of Special Rare Metal Materials, School of Chemical Engineering, Zhengzhou University, Zhengzhou, P. R.…
- Key Laboratory of Microelectronics and Energy of Henan Province, College of Physics and Electronic Engineering, Xinyang Normal University, Xinyang, P. R. China.
- College of New Energy and Intelligent Manufacturing, Henan University, Zhengzhou, P. R. China.
- Collaborative Innovation Center of Materials Science, Nankai University, Tianjin, P. R. China.
ORCID-Profile: Shasha Gao, Gonglei Shao, Zhen Zhou
Förderung
- Henan Province's Central Plains Talent Program (Cultivation Series)-Young Top Talents of Central Plains
- Natural Science Foundation of Henan Province
Zitieren
APA
Wang, C., Yang, C., Han, Y., Lei, J., Gao, S., Guo, D., Shao, G., & Zhou, Z. (2026). Regulating Metal–Support Interaction via WO 3 Crystal Phase Engineering for Enhanced Acidic Water Oxidation. Angewandte Chemie International Edition, 65(45). https://doi.org/10.1002/anie.7046071
Vancouver
Wang C, Yang C, Han Y, Lei J, Gao S, Guo D, et al. Regulating Metal–Support Interaction via WO 3 Crystal Phase Engineering for Enhanced Acidic Water Oxidation. Angewandte Chemie International Edition. 2026;65(45). doi:10.1002/anie.7046071
BibTeX
@article{Wang2026,
author = {Wang, Chaolong and Yang, Chaofan and Han, Yuna and Lei, Jiacong and Gao, Shasha and Guo, Dong and Shao, Gonglei and Zhou, Zhen},
title = {Regulating Metal–Support Interaction via WO 3 Crystal Phase Engineering for Enhanced Acidic Water Oxidation},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {45},
doi = {10.1002/anie.7046071}
}
EUVIMED